Marco Donia: Pan-cancer proteogenomics characterization of tumor immunity

Marco Donia, Associate Professor at National Center for Cancer Immune Therapy, Denmark, shared on LinkedIn:

”Pan-cancer proteogenomics characterization of tumor immunity.

Free access (Cell, Feb 14th 2024).

Highlights:

• Proteogenomics reveals seven immune subtypes spanning 10 cancer types,
• DNA alterations associate with immune subtypes and affect proteomic profiles,
• Kinase activation in immune subtypes suggests potential therapeutic targets,
• Digital pathology reveals infiltrating cells associated with immune subtypes.”

Source: Marco Donia/LinkedIn